Literature DB >> 29436490

Subthalamic stimulation and neuropsychiatric symptoms in Parkinson's disease: results from a long-term follow-up cohort study.

Marie Abbes1, Eugénie Lhommée1,2,3, Stéphane Thobois4,5,6, Hélène Klinger4,5,6, Emmanuelle Schmitt1,2,3, Amélie Bichon1,2,3, Anna Castrioto1,2,3, Jing Xie7, Valérie Fraix1,2,3, Andrea Kistner1,2,3, Pierre Pélissier1,2,3, Éric Seigneuret8, Stéphan Chabardès2,3,8, Patrick Mertens9, Emmanuel Broussolle4,5,6, Elena Moro1,2,3, Paul Krack1,2,3,10.   

Abstract

BACKGROUND: Reports on behavioural outcomes after subthalamic nucleus deep brain stimulation in Parkinson's disease are controversial and limited to short-term data. Long-term observation in a large cohort allows a better counselling and management.
METHODS: To determine whether a long-term treatment with subthalamic stimulation induces or reduces impulse control behaviours, neuropsychiatric fluctuations and apathy, 69 patients treated with subthalamic stimulation are prospectively and retrospectively assessed using Ardouin Scale of Behavior in Parkinson's Disease before and after 3-10 years of stimulation.
RESULTS: At a mean follow-up of 6 years, all impulse control disorders and dopaminergic addiction were significantly decreased, apart from eating behaviour and hypersexuality. Neuropsychiatric fluctuations also significantly improved (ON euphoria: 38% of the patients before surgery and 1% after surgery, P<0.01; OFF dysphoria: 39% of the patients before surgery and 10% after surgery, P<0.01). However, apathy increased (25% of the patients after surgery and 3% before, P<0.01). With the retrospective analysis, several transient episodes of depression, apathy, anxiety and impulse control disorders occurred.
CONCLUSIONS: Bilateral subthalamic nucleus stimulation was overall very effective in improving impulse control disorders and neuropsychiatric fluctuations in parkinsonian patients in the long term despite a counteracting frequent apathy. Transient episodes of impulse control disorders still occurred within the follow-up. These findings recommend a close follow-up in parkinsonian patients presenting with neuropsychiatric symptoms before deep brain stimulation surgery. CLINICAL TRIAL REGISTRATION: NCT01705418;Post-results. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Parkinson’s disease; apathy; dopamine; impulse control disorder; subthalamic nucleus

Mesh:

Year:  2018        PMID: 29436490     DOI: 10.1136/jnnp-2017-316373

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

Review 1.  New pharmacological and neuromodulation approaches for impulsive-compulsive behaviors in Parkinson's disease.

Authors:  Giacomo Grassi; Giovanni Albani; Federica Terenzi; Lorenzo Razzolini; Silvia Ramat
Journal:  Neurol Sci       Date:  2021-04-14       Impact factor: 3.307

Review 2.  Deep brain stimulation for the treatment of drug addiction.

Authors:  Tony R Wang; Shayan Moosa; Robert F Dallapiazza; W Jeffrey Elias; Wendy J Lynch
Journal:  Neurosurg Focus       Date:  2018-08       Impact factor: 4.047

Review 3.  Neuropsychiatric aspects of Parkinson's disease.

Authors:  Anna Nagy; Anette Schrag
Journal:  J Neural Transm (Vienna)       Date:  2019-05-29       Impact factor: 3.575

Review 4.  The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

Authors:  Daniel Weintraub; Eugenia Mamikonyan
Journal:  Am J Geriatr Psychiatry       Date:  2019-03-09       Impact factor: 4.105

5.  Preoperative REM Sleep Behavior Disorder and Subthalamic Nucleus Deep Brain Stimulation Outcome in Parkinson Disease 1 Year After Surgery.

Authors:  Elsa Besse-Pinot; Bruno Pereira; Franck Durif; Maria Livia Fantini; Elodie Durand; Bérengère Debilly; Philippe Derost; Caroline Moreau; Elodie Hainque; Tiphaine Rouaud; Alexandre Eusebio; Isabelle Benatru; Sophie Drapier; Dominique Guehl; Olivier Rascol; David Maltête; Ouhaïd Lagha-Boukbiza; Caroline Giordana; Melissa Tir; Stéphane Thobois; Lucie Hopes; Cécile Hubsch; Béchir Jarraya; Anne-Sophie Rolland; Jean-Christophe Corvol; David Devos; Ana Marques
Journal:  Neurology       Date:  2021-10-19       Impact factor: 9.910

Review 6.  Management of psychiatric disorders in Parkinson's disease : Neurotherapeutics - Movement Disorders Therapeutics.

Authors:  Daniel Weintraub
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

7.  Adaptive deep brain stimulation as advanced Parkinson's disease treatment (ADAPT study): protocol for a pseudo-randomised clinical study.

Authors:  Dan Piña-Fuentes; Martijn Beudel; Simon Little; Peter Brown; D L Marinus Oterdoom; J Marc C van Dijk
Journal:  BMJ Open       Date:  2019-06-14       Impact factor: 2.692

Review 8.  Deep Brain Stimulation of the Subthalamic Nucleus Influences Facial Emotion Recognition in Patients With Parkinson's Disease: A Review.

Authors:  Caroline Wagenbreth; Maria Kuehne; Hans-Jochen Heinze; Tino Zaehle
Journal:  Front Psychol       Date:  2019-12-03

9.  Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease.

Authors:  Marina Picillo; Onanong Phokaewvarangkul; Yu-Yan Poon; Cameron C McIntyre; Sinem Balta Beylergil; Renato P Munhoz; Suneil K Kalia; Mojgan Hodaie; Andres M Lozano; Alfonso Fasano
Journal:  Mov Disord       Date:  2020-11-09       Impact factor: 10.338

10.  The Impacts of Subthalamic Nucleus-Deep Brain Stimulation (STN-DBS) on the Neuropsychiatric Function of Patients with Parkinson's Disease Using Image Features of Magnetic Resonance Imaging under the Artificial Intelligence Algorithms.

Authors:  Wei Chen; Maode Wang; Ning Wang; Changwang Du; Xudong Ma; Qi Li
Journal:  Contrast Media Mol Imaging       Date:  2021-07-08       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.